Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators..

N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540.

2.

Recent history of vasovagal syncope in a young, referral-based population is a stronger predictor of recurrent syncope than lifetime syncope burden.

Sumner GL, Rose MS, Koshman ML, Ritchie D, Sheldon RS; Prevention of Syncope Trial Investigators..

J Cardiovasc Electrophysiol. 2010 Dec;21(12):1375-80. doi: 10.1111/j.1540-8167.2010.01848.x.

PMID:
20662990
3.

Syncope and structural heart disease: historical criteria for vasovagal syncope and ventricular tachycardia.

Sheldon R, Hersi A, Ritchie D, Koshman ML, Rose S.

J Cardiovasc Electrophysiol. 2010 Dec;21(12):1358-64. doi: 10.1111/j.1540-8167.2010.01835.x.

PMID:
20586825
4.

The development and preliminary validation of a scale measuring the impact of syncope on quality of life.

Rose MS, Koshman ML, Ritchie D, Sheldon R.

Europace. 2009 Oct;11(10):1369-74. doi: 10.1093/europace/eup106.

5.

Effect of metoprolol on quality of life in the Prevention of Syncope Trial.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Koshman ML, Ritchie D; Prevention of Syncope Trial..

J Cardiovasc Electrophysiol. 2009 Oct;20(10):1083-8. doi: 10.1111/j.1540-8167.2009.01518.x.

PMID:
19563364
6.

Design and use of a quantitative scale for measuring presyncope.

Sheldon RS, Amuah JE, Connolly SJ, Rose S, Morillo CA, Talajic M, Kus T, Fouad-Tarazi F, Klingenheben T, Krahn AD, Sheldon A, Koshman ML, Ritchie D; Investigators of the Prevention of Syncope Study..

J Cardiovasc Electrophysiol. 2009 Aug;20(8):888-93. doi: 10.1111/j.1540-8167.2009.01466.x.

PMID:
19368584
7.

Worsening of symptoms before presentation with vasovagal syncope.

Sheldon RS, Sheldon AG, Serletis A, Connolly SJ, Morillo CA, Klingenheben T, Krahn AD, Koshman ML, Ritchie D; Investigators of the Prevention of Syncope Study..

J Cardiovasc Electrophysiol. 2007 Sep;18(9):954-9.

PMID:
17655672
8.

Standard Deviation of Sequential Five-Minute R-R Interval Means (SDANN) is a prognostic marker, but not necessarily an autonomic marker.

Raj SR, Roach DE, Koshman ML, Sheldon RS.

J Am Coll Cardiol. 2006 Sep 19;48(6):1285-6; author reply 1286. No abstract available.

9.

Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.

Sheldon R, Connolly S, Rose S, Klingenheben T, Krahn A, Morillo C, Talajic M, Ku T, Fouad-Tarazi F, Ritchie D, Koshman ML; POST Investigators..

Circulation. 2006 Mar 7;113(9):1164-70.

10.

Age of first faint in patients with vasovagal syncope.

Sheldon RS, Sheldon AG, Connolly SJ, Morillo CA, Klingenheben T, Krahn AD, Koshman ML, Ritchie D; Investigators of the Syncope Symptom Study and the Prevention of Syncope Trial..

J Cardiovasc Electrophysiol. 2006 Jan;17(1):49-54.

PMID:
16426400
11.

Diagnostic criteria for vasovagal syncope based on a quantitative history.

Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML, Frenneaux M.

Eur Heart J. 2006 Feb;27(3):344-50.

12.

Role of hypotension in heart rate turbulence physiology.

Raj SR, Sheldon RS, Koshman M, Roach DE.

Heart Rhythm. 2005 Aug;2(8):820-7.

PMID:
16051116
13.

Activity-responsive pacing produces long-term heart rate variability.

Raj SR, Roach DE, Koshman ML, Sheldon RS.

J Cardiovasc Electrophysiol. 2004 Feb;15(2):179-83.

PMID:
15028048
14.

Similarity of spontaneous and induced heart rate and blood pressure turbulence.

Roach D, Koshman ML, Duff H, Sheldon R.

Can J Cardiol. 2003 Nov;19(12):1375-9.

PMID:
14631471
15.

Outcome of patients with dual-chamber pacemakers implanted for the prevention of neurally mediated syncope.

Raj SR, Koshman ML, Sheldon RS.

Am J Cardiol. 2003 Mar 1;91(5):565-9.

PMID:
12615261
16.

Induction of heart rate and blood pressure turbulence in the electrophysiologic laboratory.

Roach D, Koshman ML, Duff H, Sheldon R.

Am J Cardiol. 2002 Nov 15;90(10):1098-102.

PMID:
12423710
17.

Historical criteria that distinguish syncope from seizures.

Sheldon R, Rose S, Ritchie D, Connolly SJ, Koshman ML, Lee MA, Frenneaux M, Fisher M, Murphy W.

J Am Coll Cardiol. 2002 Jul 3;40(1):142-8.

18.

A randomized study of tilt test angle in patients with undiagnosed syncope.

Sheldon R, Koshman ML.

Can J Cardiol. 2001 Oct;17(10):1051-7.

PMID:
11694895
19.

The relationship between health-related quality of life and frequency of spells in patients with syncope.

Rose MS, Koshman ML, Spreng S, Sheldon R.

J Clin Epidemiol. 2000 Dec;53(12):1209-16.

PMID:
11146266
20.

Usefulness of clinical factors in predicting outcomes of passive tilt tests in patients with syncope.

Sheldon R, Sexton E, Koshman ML.

Am J Cardiol. 2000 Feb 1;85(3):360-4.

PMID:
11078307
Items per page

Supplemental Content

Loading ...
Support Center